Se connecter

Bibliographies thématiques / Paraneoplastic cerebellar degeneration / Articles de revues

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Paraneoplastic cerebellar degeneration.

Articles de revues sur le sujet « Paraneoplastic cerebellar degeneration »

Auteur : Grafiati

Publié le 25 janvier 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Paraneoplastic cerebellar degeneration ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Nuzhnyi, E. P., M. Yu Krasnov, A. N. Moskalenko, E. Yu Fedotova, E. O. Chekanova et S. N. Illarioshkin. « Paraneoplastic cerebellar degeneration ». Russian neurological journal 28, n^o 4 (2 octobre 2023) : 43–53. http://dx.doi.org/10.30629/2658-7947-2023-28-4-43-53.

Texte intégral

Résumé :

Introduction. Paraneoplastic cerebellar degeneration (PCD) is an immune-mediated and rapidly progressive cerebellar syndrome that develops as a result of a cross-immune response to the common antigens for the tumor and cerebellar cells. Timely diagnosis and treatment of PCD improves the functional status and survival of these patients.Objective. To analyze the clinical, laboratory and neuroimaging characteristics of PCD case series in comparison with literature data.Material and methods. 16 patients with PCD (13 women, 3 men) were examined. An assessment of the clinical presentation, brain MRI study, blood and cerebrospinal fl uid laboratory tests were carried out, the data of cancer search and patients follow-up were analyzed.Results. The median age of PCD patients was 55 years, the duration of the disease was 8.5 months (range 4 to 16 months). In 12 patients, PCD was the fi rst manifestation of cancer. The clinical prentation was presented by rapidly progressive cerebellar ataxia, often in combination with oculomotor disturbances, pyramidal and bulbar syndrome, hand tremor and dystonia. An associated cancers were detected in 13 patients (81%). Antineuronal antibodies were found in 14 patients (88%): anti-Yo-1, antibodies to amphiphysin, anti-Hu, anti-CV2 and anti-GAD. Mild atrophic changes of the cerebellum were found in 6 patients, and in 2 cases cerebellar hemiatrophy was observed.Conclusion. PCD is a rare disabling but potentially curable disease. The basis of diagnosis is the analysis of the clinical presentation and neuroimaging data, the detection of antineuronal antibodies and in fl ammatory changes in the cerebrospinal fl uid, as well as a thorough cancer search.

Styles APA, Harvard, Vancouver, ISO, etc.

2

Herdlevær, Ida, Mette Haugen, Kibret Mazengia, Cecilie Totland et Christian Vedeler. « Paraneoplastic Cerebellar Degeneration ». Neurology - Neuroimmunology Neuroinflammation 8, n^o 2 (2 février 2021) : e963. http://dx.doi.org/10.1212/nxi.0000000000000963.

Texte intégral

Résumé :

ObjectiveInvestigate the value of including cerebellar degeneration-related protein 2-like (CDR2L) as a marker in commercial diagnostic tests for anti-Yo–associated paraneoplastic cerebellar degeneration (PCD).MethodsWe included sera and CSF samples from 24 patients with suspected PCD (6 of whom had PCD with underlying gynecologic or breast cancer), who were positive for Yo antibodies using the commercially available, paraneoplastic neurologic syndromes (PNS) 14 Line Assay from Ravo Diagnostika. The samples were further evaluated using the EUROLINE PNS 12 Ag Line Assay and a cell-based assay (CBA) from Euroimmun. For confirmation of positive lineblot results, we used indirect immunofluorescence of rat cerebellar sections. We also tested all samples in 2 assays developed in-house: a CBA for CDR2L and a Western blot analysis using recombinant cerebellar degeneration-related protein 2 (CDR2) and CDR2L proteins.ResultsIn PNS 14 and PNS 12 Ag Line Assays, anti-CDR2 reactivity was observed for 24 (100%) and 20 (83%) of the 24 samples, respectively. Thirteen of 24 subjects (54%) were also positive using the Euroimmun CBA. Rat cerebellar immunofluorescence was the best confirmatory test. In our in-house CBA for CDR2L and Western blot for CDR2 and CDR2L, only the 6 patients with confirmed PCD reacted with CDR2L.ConclusionsCommercially available tests for Yo antibody detection have low specificity for PCD because these assays use CDR2 as antigen. By adding a test for CDR2L, which is the major Yo antigen, the accuracy of PCD diagnosis greatly improved.Classification of EvidenceThis study provides Class III evidence that a CBA for CDR2L accurately identifies patients with PCD.

Styles APA, Harvard, Vancouver, ISO, etc.

3

Cao, Xia, et Cai-Gang Xu. « Paraneoplastic cerebellar degeneration ». Chinese Medical Journal 133, n^o 8 (avril 2020) : 1005–7. http://dx.doi.org/10.1097/cm9.0000000000000736.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Jerome, B. Posner. « Paraneoplastic Cerebellar Degeneration ». Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 20, S3 (mai 1993) : S117—S122. http://dx.doi.org/10.1017/s0317167100048629.

Texte intégral

Résumé :

ABSTRACT:Paraneoplastic cerebellar degeneration is a rare complication of a number of cancers, particularly small cell lung cancer, gynecologic cancers and Hodgkin’s disease. The disorder is clinically characterized by rapid development of pancerebellar dysfunction, which usually does not improve, and pathologically characterized by loss of Purkinje cells with or without inflammatory infiltrates. In some but not all patients, an autoantibody that reacts with the tumor and Purkinje cells can be found in the serum and spinal fluid of patients with paraneoplastic cerebellar degeneration. The presence of the autoantibody suggests, but does not prove, that the disorder has an autoimmune mechanism for its pathogenesis.

Styles APA, Harvard, Vancouver, ISO, etc.

5

Bolla, Leela. « Paraneoplastic Cerebellar Degeneration ». Archives of Internal Medicine 157, n^o 11 (9 juin 1997) : 1258. http://dx.doi.org/10.1001/archinte.1997.00440320168016.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Shah, Trusha, Alaina Prince, Vyshak Venur et Jerome Graber. « NIRL-10 LEPTOMENINGEAL ENHANCEMENT WITH PARANEOPLASTIC CEREBELLAR DEGENERATION : AUTOIMMUNE OR METASTASES ? » Neuro-Oncology Advances 6, Supplement_1 (août 2024) : i22. http://dx.doi.org/10.1093/noajnl/vdae090.071.

Texte intégral

Résumé :

Abstract Enhancement has been occasionally reported in patients with paraneoplastic cerebellar degeneration but metastases can also occur in these patients and standard imaging and cerebrospinal cytology lack sensitivity and specificity. Among a retrospective case series of 31 patients with paraneoplastic cerebellar degeneration, 4 patients had enhancement at some point of their MRI. We report a series of four patients with paraneoplastic cerebellar degeneration with enhancement and possible concurrent or subsequent leptomeningeal metastases and review the literature. Patient 1 was a 66 year old man with merkel cell carcinoma who had subacute onset of ataxia with nausea. Initial MRI showed non enhancement cerebellar FLAIR changes. Paraneoplastic panel was negative in blood and CSF and seronegative PCD was diagnosed without response to immunosuppression. Eight months later he developed progressive cerebellar symptoms and diffuse leptomeningeal enhancement was found in the cerebellum and spine consistent with leptomeningeal metastates. Patient 2 is a 50 year old woman with HER2+ breast cancer who developed acute cerebellar symptoms with focal cerebellar enhancement and PCA1 antibody was present. Her symptoms stabilized with immune suppression and enhancement resolved, but CSF showed atypical cells suggestive of concurrent leptomeningeal metastases. Patients 3 and 4 both had serous ovarian carcinoma and subacute onset of cerebellar symptoms with cerebellar enhancement and PCA1 antibody with negative CSF cytology. Both stabilized with immune suppression but within months developed more diffuse widespread CNS nodular enhancement considered to be leptomeningeal enhancement. Enhancement is uncommon but not rare in paraneoplastic cerebellar degeneration, occurring in more than 10% of patients in this retrospective series. Others have reported enhancement in paraneoplastic cerebellar degeneration related to autoimmune process alone, but metastases can also occur and may be difficult to distinguish, creating a diagnostic and therapeutic dilemma.

Styles APA, Harvard, Vancouver, ISO, etc.

7

Kim, Sung-Hee. « Paraneoplastic Cerebellar Degeneration Presented as Acute Vertigo ». Research in Vestibular Science 21, n^o 1 (15 mars 2022) : 24–27. http://dx.doi.org/10.21790/rvs.2022.21.1.24.

Texte intégral

Résumé :

Paraneoplastic cerebellar degeneration is a rare neurological manifestation of nonmetastatic malignancy. Its usual manifestation is subacute to chronic dizziness, gait ataxia, and dysarthria. There have been only a few cases of paraneoplastic cerebellar degeneration with acute presentation. This study describes a patient with paraneoplastic cerebellar degeneration, who presented acute vestibular syndrome and then episodically developed horizontal gaze-evoked nystagmus and gait ataxia.

Styles APA, Harvard, Vancouver, ISO, etc.

8

Mizutani, T., S. Maeda, K. Hayakawa, U. Tanaka, S. Hirahata, H. Kamoshita, T. Taketani et Y. Morimatsu. « Paraneoplastic cortical cerebellar degeneration ». Acta Neuropathologica 77, n^o 2 (mars 1988) : 206–12. http://dx.doi.org/10.1007/bf00687433.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Samaha, Shehab, et Andrew J. Larner. « Cerebellar syndrome : cause cured, but symptoms persist ». Progress in Neurology and Psychiatry 27, n^o 4 (octobre 2023) : 27–29. http://dx.doi.org/10.1002/pnp.812.

Texte intégral

Résumé :

Subacute cerebellar syndromes have a broad differential diagnosis, which includes paraneoplasia. Paraneoplastic cerebellar degeneration needs to be considered in this clinical situation even if initial brain imaging is normal, and the neurological prognosis is guarded even if the underlying tumour can be successfully treated.

Styles APA, Harvard, Vancouver, ISO, etc.

10

Choi, K.-D. « Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration ». Journal of Neurology, Neurosurgery & ; Psychiatry 77, n^o 4 (1 avril 2006) : 525–28. http://dx.doi.org/10.1136/jnnp.2005.075325.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

Gupta, Dr Pushkar, Dr Rajesh Chaudhary, Dr Rizwan Khan et Punam Jakhar. « Paraneoplastic cerebellar degeneration : A rare paraneoplastic syndrome ». International Journal of Applied Research 8, n^o 6 (1 juin 2022) : 113–14. http://dx.doi.org/10.22271/allresearch.2022.v8.i6b.9831.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

12

Abdulaziz, Ammar Taha Abdullah, Xiao Qing Yu, Le Zhang, Xin Yue Jiang, Dong Zhou et Jin Mei Li. « Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism ». Medicine 97, n^o 24 (juin 2018) : e10717. http://dx.doi.org/10.1097/md.0000000000010717.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

Baloh, Robert W. « Paraneoplastic Cerebellar Disorders ». Otolaryngology–Head and Neck Surgery 112, n^o 1 (janvier 1995) : 125–27. http://dx.doi.org/10.1016/s0194-59989570311-x.

Texte intégral

Résumé :

Paraneoplastic cerebellar degeneration typically begins with rapidly progressive ataxia of the trunk and extremities. Antineuronal antibodies are found in about half the patients. The most specific autoantibody is an anti-Purkinje cell antibody found in women with gynecologic tumors. Even after the tumor is removed, the cerebellar deficit persists in most patients.

Styles APA, Harvard, Vancouver, ISO, etc.

14

Loehrer, Philipp Alexander, Lara Zieger et Ole J. Simon. « Update on Paraneoplastic Cerebellar Degeneration ». Brain Sciences 11, n^o 11 (26 octobre 2021) : 1414. http://dx.doi.org/10.3390/brainsci11111414.

Texte intégral

Résumé :

Purpose of review: To provide an update on paraneoplastic cerebellar degeneration (PCD), the involved antibodies and tumors, as well as management strategies. Recent findings: PCD represents the second most common presentation of the recently established class of immune mediated cerebellar ataxias (IMCAs). Although rare in general, PCD is one of the most frequent paraneoplastic presentations and characterized clinically by a rapidly progressive cerebellar syndrome. In recent years, several antibodies have been described in association with the clinical syndrome related to PCD; their clinical significance, however, has yet to be determined. The 2021 updated diagnostic criteria for paraneoplastic neurologic symptoms help to establish the diagnosis of PCD, direct cancer screening, and to evaluate the presence of these newly identified antibodies. Recognition of the clinical syndrome and prompt identification of a specific antibody are essential for early detection of an underlying malignancy and initiation of an appropriate treatment, which represents the best opportunity to modulate the course of the disease. As clinical symptoms can precede tumor diagnosis by years, co-occurrence of specific symptoms and antibodies should prompt continuous surveillance of the patient. Summary: We provide an in-depth overview on PCD, summarize recent findings related to PCD, and highlight the transformed diagnostic approach.

Styles APA, Harvard, Vancouver, ISO, etc.

15

Bonakis, Anastasios, Sokratis G. Papageorgiou, Dimitrios Mandellos, Eleni Galani et Nikolaos Kalfakis. « Acute onset paraneoplastic cerebellar degeneration ». Journal of Neuro-Oncology 84, n^o 3 (23 mars 2007) : 329–30. http://dx.doi.org/10.1007/s11060-007-9368-5.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Klein, Joshua P., Daniel G. Stover, Geoffrey R. Oxnard, Bruce D. Levy et Joseph Loscalzo. « Restoring Balance : Paraneoplastic Cerebellar Degeneration ». American Journal of Medicine 130, n^o 3 (mars 2017) : e85-e87. http://dx.doi.org/10.1016/j.amjmed.2016.09.035.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

17

Greenlee, John E. « Treatment of Paraneoplastic Cerebellar Degeneration ». Current Treatment Options in Neurology 15, n^o 2 (13 janvier 2013) : 185–200. http://dx.doi.org/10.1007/s11940-012-0215-4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

Mudassir, Sanaullah, Ashok Kumar, Neetu Sinha et Abhay Ranjan. « BREAST CANCER ASSOCIATED ANTI YO-ANTIBODY MEDIATED PARANEOPLASTIC CEREBELLAR DEGENERATION : CASE SERIES AND REVIEW OF LITERATURE ». MNJ (Malang Neurology Journal) 8, n^o 2 (1 juillet 2022) : 135–39. http://dx.doi.org/10.21776/ub.mnj.2022.008.02.12.

Texte intégral

Résumé :

Paraneoplastic cerebellar degeneration (PCD) is a rare immune mediated disorder characterized by progressive cerebellar ataxia in presence of onconeural antibodies which occurs due to an indirect effect of underlying malignancy i.e. small cell lung cancer (SCLC), breast and gynecologic cancer, and Hodgkin lymphoma. In about 50% of patients neurological manifestation of Paraneoplastic cerebellar degeneration occurs prior to detection of carcinoma. Anti-Yo Antibody is the commonest antibody present in patients with Paraneoplastic cerebellar degeneration which is associated with breast carcinoma. We describe 3 female patients with anti YO antibody mediated PCD with breast cancer. One patient had a previous diagnosis of breast cancer with post mastectomy status one year back. Two of them presented with ataxia and on further examination, breast lump was found. All three patients had symmetrical ataxia with one patient had severely debilitating ataxia and was not able to walk unassisted. Magnetic resonance imaging brain showed cerebellar atrophy in two patients while one patient had normal MRI. Anti- YO antibody was strongly positive in all the three patients. All patients were given immunotherapy (corticosteroids in 2, Intravenous immunoglobulin in 1) with 1 patient showed modest improvement These case highlights the need to consider for workup for paraneoplastic cerebellar degeneration in female patients presenting with subacute to chronic progressive ataxia, so that the tumors can be detected and treated in early stage with a good outcome.

Styles APA, Harvard, Vancouver, ISO, etc.

19

CARDOSI, R. J., S. L. DECESARE et W. S. ROBERTS. « Paraneoplastic cerebellar degeneration and gynecologic malignancies ». International Journal of Gynecological Cancer 7, n^o 4 (juillet 1997) : 279–83. http://dx.doi.org/10.1046/j.1525-1438.1997.00454.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

LAND, Russell, Jonathan CARTER, Roger HOUGHTON, Ken ATKINSON et Christopher DALRYMPLE. « Gynaecology meets neurology : Paraneoplastic cerebellar degeneration ». Australian and New Zealand Journal of Obstetrics and Gynaecology 45, n^o 1 (février 2005) : 79–81. http://dx.doi.org/10.1111/j.1479-828x.2005.00330.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

HENRY, Mr R. J. W., Richard HARRIES-JONES et V. K. BALAKRISHNAN. « Gynaecology meets neurology : Paraneoplastic cerebellar degeneration ». Australian and New Zealand Journal of Obstetrics and Gynaecology 45, n^o 4 (août 2005) : 342. http://dx.doi.org/10.1111/j.1479-828x.2005.00436.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

Hadjivassiliou, Marius, Stuart Currie et Nigel Hoggard. « MR spectroscopy in paraneoplastic cerebellar degeneration ». Journal of Neuroradiology 40, n^o 4 (octobre 2013) : 310–12. http://dx.doi.org/10.1016/j.neurad.2012.08.003.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

Storstein, Anette, Anette Knudsen et Christian A. Vedeler. « Proteasome antibodies in paraneoplastic cerebellar degeneration ». Journal of Neuroimmunology 165, n^o 1-2 (août 2005) : 172–78. http://dx.doi.org/10.1016/j.jneuroim.2005.04.024.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

Simonetti, D., M. Mundo, N. Micillo, G. Piran Arce, N. Mendyk, P. Santoro, A. Gardella, A. Tarulla, P. Elorza et R. Rotta Escalante. « 1-39-08 Paraneoplastic cerebellar degeneration ». Journal of the Neurological Sciences 150 (septembre 1997) : S58—S59. http://dx.doi.org/10.1016/s0022-510x(97)85125-8.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

McLELLAN, ROBERT, JOHN L. CURRIE, WALTER ROYAL et NEIL B. ROSENSHEIN. « Ovarian Carcinoma and Paraneoplastic Cerebellar Degeneration ». Obstetrics & ; Gynecology 72, n^o 6 (décembre 1988) : 922–25. http://dx.doi.org/10.1097/00006250-198812000-00023.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Shnaider, N. A., V. V. Ezhikova, Yu A. Dykhno, D. V. Dmitrenko et Yu S. Panina. « Diagnosis problems of paraneoplastic cerebellar degeneration ». Neurology, Neuropsychiatry, Psychosomatics, n^o 1 (6 mai 2014) : 35. http://dx.doi.org/10.14412/2074-2711-2014-1-35-43.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Maeda, K. « Paraneoplastic cerebellar degeneration in olfactory neuroepithelioma ». Journal of Neurology, Neurosurgery & ; Psychiatry 77, n^o 1 (1 janvier 2006) : 123–24. http://dx.doi.org/10.1136/jnnp.2005.066977.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Scheid, R. « Clinical insights into paraneoplastic cerebellar degeneration ». Journal of Neurology, Neurosurgery & ; Psychiatry 77, n^o 4 (1 avril 2006) : 529–30. http://dx.doi.org/10.1136/jnnp.2005.082206.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

29

Waterhouse, David M., Ronald B. Natale et Robert L. Cody. « Breast cancer and paraneoplastic cerebellar degeneration ». Cancer 68, n^o 8 (15 octobre 1991) : 1835–41. http://dx.doi.org/10.1002/1097-0142(19911015)68:8<1835 ::aid-cncr2820680833>3.0.co;2-n.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

30

Anderson, Neil E., Marchc K. Rosenblum et Jerome B. Posner. « Paraneoplastic cerebellar degeneration : Clinical-immunological correlations ». Annals of Neurology 24, n^o 4 (octobre 1988) : 559–67. http://dx.doi.org/10.1002/ana.410240413.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

31

McLellan, R., JL Currie, W. Royal et NB Rosenshein. « Ovarian carcinoma and paraneoplastic cerebellar degeneration ». International Journal of Gynecology & ; Obstetrics 29, n^o 3 (juillet 1989) : 282. http://dx.doi.org/10.1016/0020-7292(89)90298-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

32

Gracien, RM, M. Kordulla et U. Ziemann. « Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing–remitting multiple sclerosis ». Multiple Sclerosis Journal 17, n^o 4 (8 décembre 2010) : 498–500. http://dx.doi.org/10.1177/1352458510389488.

Texte intégral

Résumé :

Paraneoplastic cerebellar degeneration (PCD) is a rare non-metastatic complication of cancer mediated by T lymphocytes and auto-antibodies directed against Purkinje cells of the cerebellum. We report a patient with relapsing–remitting multiple sclerosis who developed a progressive cerebellar syndrome with dysarthria, ataxic gait and vertigo mimicking development of secondary progressive multiple sclerosis but caused by anti-Yo antibody positive PCD associated with ovarian cancer, presenting an unusual diagnostic challenge.

Styles APA, Harvard, Vancouver, ISO, etc.

33

Sahoo, Debananda, Anupam Dey, Anil Dash et Arpita Dash. « Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody ». BMJ Case Reports 17, n^o 1 (janvier 2024) : e257435. http://dx.doi.org/10.1136/bcr-2023-257435.

Texte intégral

Résumé :

Paraneoplastic neurological syndromes (PNS) are a group of disorders with diverse neurological manifestations that are observed in patients with various types of cancer. Any portion of the nervous system can be affected by these syndromes, which are brought on by processes other than metastasis, direct tumour spread or chemotherapy side effects. An immune-mediated attack on the cerebellar Purkinje cells and consequent cerebellar symptoms define paraneoplastic cerebellar degeneration(PCD), a subtype of the PNS. Axonal or demyelinating paraneoplastic peripheral neuropathies are both possible. Here, we describe the case of a middle-aged woman who presented with subacute-onset cerebellar symptoms and peripheral neuropathy, was discovered to have a positive anti-Yo antibody, and was later detected to have an ovarian mass. This case illustrates the significance of considering a paraneoplastic aetiology in patients with otherwise unexplained neurological manifestations and initiating an appropriate workup and early treatment for the primary malignancy.

Styles APA, Harvard, Vancouver, ISO, etc.

34

Medeiros, Milton César Rodrigues, Milton Takeshi Medeiros et Damacio Ramon Kaimen Maciel. « Paraneoplastic cerebellar degeneration preceding diagnosis of breast adenocarcinoma ». Journal Archives of Health 4, n^o 4 (28 novembre 2023) : 1195–98. http://dx.doi.org/10.46919/archv4n4-010.

Texte intégral

Résumé :

We report a case of a 40 years old patient presenting with paraneoplastic cerebellar degeneration. The diagnosis was made based on the clinical picture of axial and appendicular ataxia, associated with findings on MRI and confirmed by the presence of anti-Yo and anti-Ri antibodies in cerebral spine fluid. From this diagnosis, the search for neoplasm began. An invasive carcinoma was then detected by breast biopsy. Surgical treatment was then carried out with subsequent chemotherapy and radiotherapy. With specific cancer treatment, there was a significant improvement in cerebellar symptoms. The case described shows the importance of the neurologist keeping paraneoplastic syndrome in mind in their differential diagnosis list for cerebellar symptoms and signs of insidious onset.

Styles APA, Harvard, Vancouver, ISO, etc.

35

Suri, Vinit, Nilesh Jadhao, NadeemI Khan et Rohan Gupta. « Paraneoplastic cerebellar degeneration in Hodgkin′s lymphoma ». Annals of Indian Academy of Neurology 15, n^o 3 (2012) : 205. http://dx.doi.org/10.4103/0972-2327.99720.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

Kenney, S. H., P. D. Bromwich et D. H. Barlow. « Paraneoplastic cerebellar degeneration associated with uterine leiomyomata ». Journal of Obstetrics and Gynaecology 10, n^o 1 (janvier 1989) : 66. http://dx.doi.org/10.3109/01443618909151107.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

37

Baker, P., A. Mackie et M. Macpherson. « Paraneoplastic cerebellar degeneration associated with uterine leiomyomata ». Journal of Obstetrics and Gynaecology 10, n^o 1 (janvier 1989) : 66–67. http://dx.doi.org/10.3109/01443618909151108.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

38

Levite, R., A. Fishman, A. Kesler, M. Altaras et N. Gadoth. « Paraneoplastic cerebellar degeneration heralding fallopian tube adenocarcinoma ». International Journal of Gynecological Cancer 11, n^o 2 (mars 2001) : 169–71. http://dx.doi.org/10.1046/j.1525-1438.2001.00065.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

39

Levite, R., A. Fishman, A. Kesler, M. Altaras et N. Gadoth. « Paraneoplastic cerebellar degeneration heralding fallopian tube adenocarcinoma ». International Journal of Gynecological Cancer 11, n^o 2 (27 mars 2001) : 169–71. http://dx.doi.org/10.1046/j.1525-1438.2001.011002169.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

40

RUSSO, ALESSIA ERIKA, SIMONA SCALONE, GIULIA COSTANZA LEONARDI, AURORA SCALISI, GIORGIO GIORDA et ROBERTO SORIO. « Paraneoplastic cerebellar degeneration associated with ovarian cancer ». Oncology Letters 5, n^o 2 (7 novembre 2012) : 681–83. http://dx.doi.org/10.3892/ol.2012.1016.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

Hahn, A., A. Claviez, G. Brinkmann, H. J. Altermatt, R. Schneppenheim et U. Stephani. « Paraneoplastic Cerebellar Degeneration in Pediatric Hodgkin Disease ». Neuropediatrics 31, n^o 1 (février 2000) : 42–44. http://dx.doi.org/10.1055/s-2000-15297.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

42

Freitas, Diana, Ana Marques, Joana Cunha, Catarina Portela et Rui Nabiço. « PR95 PARANEOPLASTIC CEREBELLAR DEGENERATION AND BREAST CANCER ». Breast 24 (novembre 2015) : S54. http://dx.doi.org/10.1016/s0960-9776(15)30107-7.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Tanaka, Yudai, Nao Suzuki, Masaki Takao, Akiko Ichikawa, Nobuyuki Susumu et Daisuke Aoki. « Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma ». Gynecologic Oncology 99, n^o 2 (novembre 2005) : 500–503. http://dx.doi.org/10.1016/j.ygyno.2005.06.064.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Bataller, L., E. Fages et C. Alberola. « Paraneoplastic cerebellar degeneration and anti-Yo antibodies ». Neurología (English Edition) 26, n^o 5 (2011) : e3-e4. http://dx.doi.org/10.1016/s2173-5808(11)70072-4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

45

Slattery, C. F., M. Agius et R. Zaman. « Bipolar disorder associated with paraneoplastic cerebellar degeneration ». European Psychiatry 23 (avril 2008) : S224. http://dx.doi.org/10.1016/j.eurpsy.2008.01.398.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

46

Schlake, Hans-Peter, Ingo Wilhelm Husstedt, Karl-Heinz Grotemeyer et Richard Pötter. « Paraneoplastic subacute cerebellar degeneration in Hodgkin's disease ». Clinical Neurology and Neurosurgery 91, n^o 4 (janvier 1989) : 329–35. http://dx.doi.org/10.1016/0303-8467(89)90010-3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

47

Wessel, K., H. C. Diener, G. Schroth et J. Dichgans. « Paraneoplastic cerebellar degeneration associated with Hodgkin's disease ». Journal of Neurology 235, n^o 2 (1987) : 122–24. http://dx.doi.org/10.1007/bf00718025.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

48

Rico, I. Vazquéz, R. Cabra Rodríguez, B. Rodríguez Bayona, A. Barco Sánchez, M. Á. Castaño López et A. León-Justel. « Anti-Hu antibody-mediated paraneoplastic cerebellar degeneration ». Clinica Chimica Acta 493 (juin 2019) : S122—S123. http://dx.doi.org/10.1016/j.cca.2019.03.260.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

49

Solà-Valls, Núria, Lydia Gaba, Esteban Muñoz, Begoña Mellado, Teresa Ribalta, Albert Saiz et Francesc Graus. « Paraneoplastic cerebellar degeneration associated with thymic germinoma ». Journal of the Neurological Sciences 320, n^o 1-2 (septembre 2012) : 153–55. http://dx.doi.org/10.1016/j.jns.2012.06.021.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

50

Jain, Vanita, Sudesh Prabhakar, Rashmi Bagga, Jaswinder Kalra et Sarala Gopalan. « Paraneoplastic cerebellar degeneration with ovarian endometroid carcinoma ». Acta Obstetricia et Gynecologica Scandinavica 82, n^o 7 (juillet 2003) : 672–73. http://dx.doi.org/10.1034/j.1600-0412.2003.00169.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!